BMC Gastroenterology

official impact factor 2.47

Open Access Highly Access Pre-publication history

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo*, Nuria Fernández, Francisca L Sousa, Encarnación Cabrera, Manuel Castro, Luz M Ramírez, Robin Rivera, Esther Ubiña, Francisco Vera, Isabel Méndez, Francisco Rivas-Ruiz, José L Moreno and Emilio Perea-Milla

BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 22 Dec 2006
Reviewer's Report Giovanni Cammarota 10 Feb 2007
Reviewer's Report TJ Borody 19 Feb 2007
Reviewer's Report Colm O'Morain 07 Mar 2007
Resubmission - Version 2 Manuscript Author's comment 28 Mar 2007
Resubmission - Version 3 Manuscript 29 Mar 2007
Reviewer's Report TJ Borody 27 Apr 2007
Reviewer's Report Colm O'Morain 21 May 2007
Resubmission - Version 6 Manuscript Author's comment 05 Jul 2007
Editorial acceptance 10 Jul 2007
Published 25 Jul 2007